ARYA Sciences Acquisition Corp IV
ARYD · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $4,752 | $1,009 | $6,614 | $41 |
| SG&A Expenses | $4,752 | $1,009 | $6,614 | $14 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $13 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4,752 | $1,009 | $6,614 | $14 |
| Operating Income | -$4,752 | -$1,009 | -$6,614 | -$14 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2,619 | $2,077 | $52 | $0 |
| Pre-Tax Income | -$2,133 | $1,067 | -$6,562 | -$14 |
| Tax Expense | $0 | -$2,077 | $0 | $0 |
| Net Income | -$2,133 | $1,067 | -$6,562 | -$14 |
| % Margin | – | – | – | – |
| EPS | -0.22 | 0.16 | -0.4 | -0.001 |
| % Growth | -237.5% | 140% | -57,042.9% | – |
| EPS Diluted | -0.22 | 0.16 | -0.4 | -0.001 |
| Weighted Avg Shares Out | 9,809 | 19,187 | 16,540 | 19,187 |
| Weighted Avg Shares Out Dil | 9,809 | 19,187 | 16,540 | 19,187 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $4,752 | $1,009 | $0 | $41 |
| EBITDA | -$4,752 | -$1,009 | $52 | -$14 |
| % Margin | – | – | – | – |